Funds holding VISTAGEN THERAPEUTICS INC
ISIN US92840H4002 · United States
- Fund holders
- 9
- Of which ETFs
- 1 8 other funds
- Value held
- ≈ 711.6K $ 691.8K $ · 16.9K €
- Share of capital
- 5.8 % of 41M shares on Jun 12, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,160,455 | 262.3K $ | 2.83 % | as of Jun 30, 2026 ↗ | |
| AdvisorShares Psychedelics ETF AdvisorShares Trust | 438,643 | 99.1K $ | 0.22 % | 1.07 % | as of Jun 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 413,745 | 93.5K $ | 0.00 % | 1.01 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 266,141 | 167.7K $ | 0.00 % | 0.65 % | as of May 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 48,903 | 30.8K $ | 0.12 % | as of May 31, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 46,961 | 29.6K $ | 0.11 % | as of May 31, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 12,189 | 7.7K $ | 0.03 % | as of May 31, 2026 ↗ | |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 4,947 | 1.1K $ | 0.01 % | as of Jun 30, 2026 ↗ | |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 16.9K € | 0.02 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| AdvisorShares Psychedelics ETF AdvisorShares Trust | 0.22 % | as of Jun 30, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 0.02 % | as of Dec 31, 2025 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 8 | -4 | 2,391,984 | +3.9 % |
| 2026Q2 | 12 | -8 | 2,302,717 | -2.8 % |
| 2026Q1 | 20 | -1 | 2,368,829 | +10.2 % |
| 2025Q4 | 21 | +4 | 2,150,167 | -8.3 % |
| 2025Q3 | 17 | 0 | 2,344,758 | -4.9 % |
| 2025Q2 | 17 | +3 | 2,465,094 | +0.6 % |
| 2025Q1 | 14 | 0 | 2,449,339 | +9.9 % |
| 2024Q4 | 14 | +1 | 2,228,046 | +4.3 % |
| 2024Q3 | 13 | -1 | 2,136,729 | -0.4 % |
| 2024Q2 | 14 | +3 | 2,144,463 | +7.9 % |
| 2024Q1 | 11 | +2 | 1,986,804 | +560.9 % |
| 2023Q4 | 9 | 300,613 |
Institutional managers
53 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| ORBIMED ADVISORS LLC | 3,060,000 | 1.7M $ | as of Mar 31, 2026 |
| TCG Crossover Management, LLC | 2,676,580 | 1.5M $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 751,141 | 429.3K $ | as of Mar 31, 2026 |
| STEMPOINT CAPITAL LP | 616,749 | 58.2K $ | as of Mar 31, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | 589,663 | 336 $ | as of Mar 31, 2026 |
| Ikarian Capital, LLC | 519,077 | 296.7K $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 469,619 | 268.4K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 453,391 | 259.2K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 448,507 | 256.3K $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 430,404 | 246K $ | as of Mar 31, 2026 |
| LUMINUS MANAGEMENT LLC | 396,053 | 226.3K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 291,300 | 166.5K $ | as of Mar 31, 2026 |
| AdvisorShares Investments LLC | 277,110 | 158.4K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 272,811 | 155.9K $ | as of Mar 31, 2026 |
| Verdad Advisers, LP | 184,938 | 105.7K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 152,849 | 87.4K $ | as of Mar 31, 2026 |
| Shay Capital LLC | 144,452 | 82.6K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 142,607 | 81.5K $ | as of Mar 31, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | 134,571 | 76.9K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 121,114 | 69.2K $ | as of Mar 31, 2026 |
| TUDOR INVESTMENT CORP ET AL | 106,172 | 60.7K $ | as of Mar 31, 2026 |
| DIADEMA PARTNERS LP | 105,428 | 60.3K $ | as of Mar 31, 2026 |
| SIMPLEX TRADING, LLC | 89,649 | 51.3K $ | as of Mar 31, 2026 |
| UBS Group AG | 78,736 | 45K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 72,655 | 41.5K $ | as of Mar 31, 2026 |
Declared shareholders of VISTAGEN THERAPEUTICS INC
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Commodore Capital LP and 3 others | 9.90 % | 4,244,590 | as of Aug 14, 2026 · SCHEDULE 13G |
| TCG Crossover GP I, LLC and 4 others | 6.70 % | 2,960,404 | as of Jun 30, 2026 · SCHEDULE 13G |
| ORBIMED ADVISORS LLC and 1 other | 0.00 % | 0 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding VISTAGEN THERAPEUTICS INC". https://titelia.com/en/stocks/vistagen-therapeutics-inc-US92840H4002